Table 1.
Patient Characteristics
| Characteristics | All (n = 537) |
|---|---|
| Age, median in years (IQR) | 57 (46–65) |
| Male sex, n (%) | 323 (60.1) |
| Type of Transplant, n (%) Kidney Liver Lung Heart Kidney-pancreas or kidney-islet Others |
258 (48) 120 (22.3) 80 (14.9) 58 (10.8) 15 (2.8) 6 (1.1) |
| Time From Transplant to First Dose of Vaccine in Years, Median (IQR) | 4 (1–11) |
| Within 1 year of transplant, n (%) | 74 (13.8) |
| Rejection in preceding 3 months, n (%) | 10 (1.9) |
| CKD eGFR <30, n (%) | 68 (12.7) |
| Immunosuppression, n (%) Prednisone Tacrolimus Cyclosporin Mycophenolate Azathioprine Sirolimus |
352 (65.8) 443 (83) 44 (8.2) 369 (68.8) 45 (8.4) 46 (8.6) |
| Vaccine Brand by Dose (%) 1st BNT162b2/mRNA-1273/AZD1222 2nd BNT162b2/mRNA-1273/AZD1222 3rd BNT162b2/mRNA-1273/AZD1222 |
438/83/16 (81.6/15.5/3) 445/80/12 (82.9/14.9/2.2) 368/102/0 (77.6/21.5/0) |
Abbreviations: CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; IQR, interquartile range.